NAILA GOLDENBERG: Open Payments
NPI 1396796330 · MASON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,968 in 145 payments from 30 companies in 2025. Trend: 2023 $3,442 · 2024 $3,361 · 2025 $2,968
Food & beverage: $2,960Education: $8
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $251 |
| KYOWA KIRIN, INC. | 8 | $248 |
| Lilly USA, LLC | 15 | $243 |
| Xeris Pharmaceuticals, Inc. | 8 | $236 |
| Ascendis Pharma Endocrinology Inc | 9 | $185 |
| BETA BIONICS, INC. | 9 | $181 |
| Amgen Inc. | 9 | $174 |
| ABBVIE INC. | 14 | $169 |
| RECORDATI_RARE_DISEASES_INC. | 7 | $157 |
| Neurocrine BioSciences, Inc. | 3 | $148 |
Products named: RECORLEV, Yorvipath, iLet Bionic Pancreas, MOUNJARO, JARDIANCE, Repatha, ISTURISA, CRENESSITY.
Industry payments across OH — which companies pay providers there.
